These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19012864)

  • 21. Deep phenotyping for precision medicine in Parkinson's disease.
    Schalkamp AK; Rahman N; Monzón-Sandoval J; Sandor C
    Dis Model Mech; 2022 Jun; 15(6):. PubMed ID: 35647913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eigenbehaviour as an Indicator of Cognitive Abilities.
    Botros AA; Schuetz N; Röcke C; Weibel R; Martin M; Müri RM; Nef T
    Sensors (Basel); 2022 Apr; 22(7):. PubMed ID: 35408381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indoor Location Data for Tracking Human Behaviours: A Scoping Review.
    Shum LC; Faieghi R; Borsook T; Faruk T; Kassam S; Nabavi H; Spasojevic S; Tung J; Khan SS; Iaboni A
    Sensors (Basel); 2022 Feb; 22(3):. PubMed ID: 35161964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonwearable Sensor-Based In-Home Assessment of Subtle Daily Behavioral Changes as a Candidate Biomarker for Mild Cognitive Impairment.
    Yamasaki T; Kumagai S
    J Pers Med; 2021 Dec; 12(1):. PubMed ID: 35055326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wearable, Environmental, and Smartphone-Based Passive Sensing for Mental Health Monitoring.
    Sheikh M; Qassem M; Kyriacou PA
    Front Digit Health; 2021; 3():662811. PubMed ID: 34713137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer's Disease and Mild Cognitive Impairment.
    Yamada Y; Shinkawa K; Kobayashi M; Caggiano V; Nemoto M; Nemoto K; Arai T
    J Alzheimers Dis; 2021; 84(1):315-327. PubMed ID: 34542076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity and Cultural Generalisability of a 5-Minute AI-Based, Computerised Cognitive Assessment in Mild Cognitive Impairment and Alzheimer's Dementia.
    Kalafatis C; Modarres MH; Apostolou P; Marefat H; Khanbagi M; Karimi H; Vahabi Z; Aarsland D; Khaligh-Razavi SM
    Front Psychiatry; 2021; 12():706695. PubMed ID: 34366938
    [No Abstract]   [Full Text] [Related]  

  • 28. Insights Into the Older Adults' World: Concepts of Aging, Care, and Using Assistive Technology in Late Adulthood.
    Wilkowska W; Offermann-van Heek J; Laurentius T; Bollheimer LC; Ziefle M
    Front Public Health; 2021; 9():653931. PubMed ID: 34277537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of But Not Capacity for Participation in Everyday Activities Is Associated With Cognitive Impairment in Late Life.
    Wu CY; Rodakowski J; Terhorst L; Dew MA; Butters M; Karp JF; Albert SM; Gildengers AG; Reynolds CF; Skidmore ER
    J Appl Gerontol; 2021 Nov; 40(11):1579-1586. PubMed ID: 33406968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional parameters indicative of mild cognitive impairment: a systematic review using instrumented kinematic assessment.
    Fuentes-Abolafio IJ; Stubbs B; Pérez-Belmonte LM; Bernal-López MR; Gómez-Huelgas R; Cuesta-Vargas A
    BMC Geriatr; 2020 Aug; 20(1):282. PubMed ID: 32778071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential of Ambient Sensor Systems for Early Detection of Health Problems in Older Adults.
    Saner H; Schütz N; Botros A; Urwyler P; Buluschek P; du Pasquier G; Nef T
    Front Cardiovasc Med; 2020; 7():110. PubMed ID: 32760739
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term digital device-enabled monitoring of functional status: Implications for management of persons with Alzheimer's disease.
    Manley NA; Bayen E; Braley TL; Merrilees J; Clark AM; Zylstra B; Schaffer M; Bayen AM; Possin KL; Miller BL; Schenk AK; Bonasera SJ
    Alzheimers Dement (N Y); 2020; 6(1):e12017. PubMed ID: 32548234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early Detection of Mild Cognitive Impairment With In-Home Sensors to Monitor Behavior Patterns in Community-Dwelling Senior Citizens in Singapore: Cross-Sectional Feasibility Study.
    Rawtaer I; Mahendran R; Kua EH; Tan HP; Tan HX; Lee TS; Ng TP
    J Med Internet Res; 2020 May; 22(5):e16854. PubMed ID: 32369031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of Step Angle for Quantifying the Gait Impairment of Parkinson's Disease by Wearable Sensors: Controlled Study.
    Wang J; Gong D; Luo H; Zhang W; Zhang L; Zhang H; Zhou J; Wang S
    JMIR Mhealth Uhealth; 2020 Mar; 8(3):e16650. PubMed ID: 32196458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current State of Digital Biomarker Technologies for Real-Life, Home-Based Monitoring of Cognitive Function for Mild Cognitive Impairment to Mild Alzheimer Disease and Implications for Clinical Care: Systematic Review.
    Piau A; Wild K; Mattek N; Kaye J
    J Med Internet Res; 2019 Aug; 21(8):e12785. PubMed ID: 31471958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validity of pervasive computing based continuous physical activity assessment in community-dwelling old and oldest-old.
    Schütz N; Saner H; Rudin B; Botros A; Pais B; Santschi V; Buluschek P; Gatica-Perez D; Urwyler P; Marchal-Crespo L; Müri RM; Nef T
    Sci Rep; 2019 Jul; 9(1):9662. PubMed ID: 31273234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. When Will My Patient Fall? Sensor-Based In-Home Walking Speed Identifies Future Falls in Older Adults.
    Piau A; Mattek N; Crissey R; Beattie Z; Dodge H; Kaye J
    J Gerontol A Biol Sci Med Sci; 2020 Apr; 75(5):968-973. PubMed ID: 31095283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smart Home-Based Prediction of Multidomain Symptoms Related to Alzheimer's Disease.
    Alberdi A; Weakley A; Schmitter-Edgecombe M; Cook DJ; Aztiria A; Basarab A; Barrenechea M
    IEEE J Biomed Health Inform; 2018 Nov; 22(6):1720-1731. PubMed ID: 29994359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials.
    Gold M; Amatniek J; Carrillo MC; Cedarbaum JM; Hendrix JA; Miller BB; Robillard JM; Rice JJ; Soares H; Tome MB; Tarnanas I; Vargas G; Bain LJ; Czaja SJ
    Alzheimers Dement (N Y); 2018; 4():234-242. PubMed ID: 29955666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of nonintrusive sensor-based information and communication technology for real-world evidence for clinical trials in dementia.
    Teipel S; König A; Hoey J; Kaye J; Krüger F; Robillard JM; Kirste T; Babiloni C
    Alzheimers Dement; 2018 Sep; 14(9):1216-1231. PubMed ID: 29936147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.